NovaBay Pharmaceuticals Inc (NBY)
0.1186
0.00 (0.00%)
USD |
NYAM |
May 17, 16:00
0.1214
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Debt to Equity Ratio: 6.294 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 6.294 |
December 31, 2023 | 0.3431 |
September 30, 2023 | 0.1805 |
June 30, 2023 | 0.1384 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.0103 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.0075 |
June 30, 2020 | 0.531 |
March 31, 2020 | -6.315 |
December 31, 2019 | 2.684 |
September 30, 2019 | 1.042 |
June 30, 2019 | 1.656 |
March 31, 2019 | 1.989 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | -0.2124 |
March 31, 2016 | -0.4196 |
December 31, 2015 | -0.3246 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.315
Minimum
Mar 2020
6.294
Maximum
Mar 2024
0.3285
Average
0.0037
Median
Debt to Equity Ratio Benchmarks
Eyenovia Inc | 8.205 |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 5.357M |
Total Liabilities (Quarterly) | 5.197M |
Shareholders Equity (Quarterly) | 0.16M |
Current Ratio | 0.9151 |
Net Debt Paydown Yield | -6.01% |